RESUMEN
Oral nutritional supplement drinks (ONS) are beverages high in dairy proteins that are prescribed to individuals at risk of malnutrition. Consumption of ONS is poor in elderly care facilities, with patients commenting that the sensory attributes of these drinks reduce their enjoyment and willingness to consume. Mouth drying is an attribute of ONS found to build with repeated consumption, which may further limit liking of these products. This study investigated the sources of drying sensations by sequential profiling, with a trained sensory panel rating a range of model milk systems and ONS over repeated sips and during after-effects. Sequential profiling found that fortification of milk with both caseinate and whey protein concentrate significantly increased the perception of mouth drying over repeated consumption, increasing by between 35 and 85% over consumption of 40mL. Enrichment of ONS with either whey protein concentrate or milk protein concentrate to a total protein content of 8.7% (wt/wt) resulted in whey and casein levels of 4.3:4.4% and 1.7:7.0% respectively. The product higher in whey protein was substantially more mouth drying, implying that whey proteins may be the most important contributor to mouth drying in ONS. However, efforts to mask mouth drying of protein-fortified milk by increasing sweetness or fat level were unsuccessful at the levels tested. Increasing the viscosity of protein-fortified milk led to a small but significant reduction in mouth drying. However, this approach was not successful when tested within complete ONS. Further analysis is required into the mechanism of protein-derived mouth drying to mask negative sensations and improve the enjoyment and consumption of protein-rich ONS.
Asunto(s)
Bebidas/análisis , Caseínas/química , Productos Lácteos/análisis , Proteínas de la Leche/análisis , Boca , Animales , Suplementos Dietéticos , Leche/química , Gusto , Viscosidad , Proteína de Suero de LecheRESUMEN
Calcium chloride (0-25 mM) was added to skim milk powder that was reconstituted to 9% total solids. Heat stability was evaluated between 60 and 120°C for different times by observing whether samples had coagulated, and by measuring the amount of sediment and residual protein in the centrifuged supernatant. Milk samples were also dialyzed during their respective heat treatments to recover the soluble phase at different temperatures to measure pH and ionic calcium. The transition conditions between good and poor heat stability were established for different calcium chloride concentrations and temperatures. As temperature increased, coagulation occurred at lower levels of added calcium chloride. The transition was quite distinct at higher temperatures but less so at lower temperatures; it was initiated by an increase in sediment formation before a firm coagulum was formed. Both pH and ionic calcium decreased in dialysates as temperature increased. No coagulation was observed if Ca(2+) was <0.5 mM and pH was >6.3 in dialysates taken at their respective coagulation temperatures. Being able to measure pH and ionic calcium at high temperatures will allow better understanding of factors affecting heat stability. Electrophoresis of the supernatants permitted identification of the protein fractions participating in the coagulation process. When coagulation was observed below 80°C, substantial amounts of undenatured ß-lactoglobulin and α-lactalbumin were found in the supernatant, as well as some soluble casein fractions. All the major whey protein and casein fractions were found in the sediment.
Asunto(s)
Cloruro de Calcio/análisis , Suplementos Dietéticos/análisis , Calor , Leche/química , Animales , Calcio/análisis , Caseínas/análisis , Diálisis , Conservación de Alimentos , Concentración de Iones de Hidrógeno , Proteínas de la Leche/análisis , Polvos , Proteína de Suero de LecheRESUMEN
Streptococcus uberis is an important environmental mastitis pathogen that causes subclinical and clinical mastitis in lactating and nonlactating cows and heifers throughout the world. Previous work from our laboratory suggests that S. uberis adhesion molecule (SUAM) is involved in S. uberis pathogenesis and may be an excellent target for vaccine development. The objective of this study was to evaluate the antibody response of cattle vaccinated with recombinant SUAM (rSUAM). Uninfected primiparous dairy cows (n=30) in late lactation were divided randomly into three groups of 10 cows each: control, 200 µg rSUAM, and 400 µg rSUAM. Cows in groups vaccinated with 200 µg and 400 µg rSUAM received an emulsion containing adjuvant, phosphate-buffered saline (PBS) and affinity purified rSUAM. Cows in the control group received an emulsion containing adjuvant and PBS. Cows were vaccinated subcutaneously in the neck region at drying off (D-0), 28 d after drying off (D+28) and within 7 d after calving. Serum was collected at D-0, D+28, at calving (C-0), calving vaccination (CV), and during early lactation (CV+14). Serum antibody responses were measured by an ELISA against rSUAM. Following the first vaccination a significant increase in anti-rSUAM antibodies was detected at D+28 in cows from groups vaccinated with 200 µg and 400 µg rSUAM when compared to the control group. This increase in anti-rSUAM antibodies continued following the second immunization at D+28; reaching the highest levels in the post-parturient sampling period (C0), after which antibodies appeared to plateau. S. uberis UT888 pretreated with several dilutions of heat-inactivated serum from cows vaccinated with rSUAM, affinity purified antibodies against rSUAM, and to a 17 amino acid long peptide from the N terminus of SUAM (pep-SUAM) were co-cultured with bovine mammary epithelial cells and adherence to and internalization of S. uberis into epithelial cells was measured. Compared to untreated controls, opsonization of two strains of S. uberis with sera from cows vaccinated with rSUAM, with affinity purified rSUAM antibodies, or with affinity purified pep-SUAM antibodies significantly reduced adherence to and internalization of this pathogen into bovine mammary epithelial cells. In conclusion, subcutaneous vaccination of dairy cows with rSUAM during physiological transitions of the mammary gland either from or to a state of active milk synthesis induced antibodies in serum and milk and these antibodies reduced adherence to and internalization of S. uberis into mammary epithelial cells under in vitro conditions. SUAM appears to be an excellent candidate for vaccine development.
Asunto(s)
Vacunas Bacterianas/inmunología , Moléculas de Adhesión Celular/inmunología , Células Epiteliales/microbiología , Mastitis Bovina/prevención & control , Streptococcus/fisiología , Animales , Anticuerpos Antibacterianos/análisis , Adhesión Bacteriana/inmunología , Adhesión Bacteriana/fisiología , Proteínas Bacterianas/química , Proteínas Bacterianas/inmunología , Proteínas Bacterianas/metabolismo , Bovinos , Calostro/química , Industria Lechera , Femenino , Glándulas Mamarias Animales/citología , Mastitis Bovina/microbiología , Proteínas Recombinantes/inmunología , Proteínas Recombinantes/metabolismo , Suero , Streptococcus/inmunología , Vacunas Sintéticas/inmunologíaRESUMEN
Lactoperoxidase (LP) exerts antimicrobial effects in combination with H(2)O(2) and either thiocyanate (SCN(-)) or a halide (e.g., I(-)). Garlic extract in the presence of ethanol has also been used to activate the LP system. This study aimed to determine the effects of 3 LP activation systems (LP+SCN(-)+H(2)O(2); LP+I(-)+H(2)O(2); LP + garlic extract + ethanol) on the growth and activity of 3 test organisms (Staphylococcus aureus, Pseudomonas aeruginosa, and Bacillus cereus). Sterilized milk was used as the reaction medium, and the growth pattern of the organisms and a range of keeping quality (KQ) indicators (pH, titratable acidity, ethanol stability, clot on boiling) were monitored during storage at the respective optimum growth temperature for each organism. The LP+I(-)+ H(2)O(2) system reduced bacterial counts below the detection limit shortly after treatment for all 3 organisms, and no bacteria could be detected for the duration of the experiment (35 to 55 h). The KQ data confirmed that the milk remained unspoiled at the end of the experiments. The LP + garlic extract + ethanol system, on the other hand, had no effect on the growth or KQ with P. aeruginosa, but showed a small retardation of growth of the other 2 organisms, accompanied by small increases (5 to 10 h) in KQ. The effects of the LP+SCN(-)+H(2)O(2) system were intermediate between those of the other 2 systems and differed between organisms. With P. aeruginosa, the system exerted total inhibition within 10 h of incubation, but the bacteria regained viability after a further 5 h, following a logarithmic growth curve. This was reflected in the KQ indicators, which implied an extension of 15 h. With the other 2 bacterial species, LP+SCN(-)+H(2)O(2) exerted an obvious inhibitory effect, giving a lag phase in the growth curve of 5 to 10 h and KQ extension of 10 to 15 h. When used in combination, I(-) and SCN(-) displayed negative synergy.
Asunto(s)
Activación Enzimática , Conservación de Alimentos/métodos , Lactoperoxidasa/farmacología , Leche/microbiología , Animales , Bacillus cereus/efectos de los fármacos , Bacillus cereus/crecimiento & desarrollo , Bovinos , Cromatografía Líquida de Alta Presión , Recuento de Colonia Microbiana , Estabilidad de Enzimas , Etanol/farmacología , Femenino , Ajo/química , Peróxido de Hidrógeno/farmacología , Yoduros/farmacología , Lactoperoxidasa/metabolismo , Pruebas de Sensibilidad Microbiana , Leche/normas , Extractos Vegetales/farmacología , Pseudomonas aeruginosa/efectos de los fármacos , Pseudomonas aeruginosa/crecimiento & desarrollo , Staphylococcus aureus/efectos de los fármacos , Staphylococcus aureus/crecimiento & desarrollo , Tiocianatos/farmacología , Factores de TiempoRESUMEN
BACKGROUND: Various mechanisms have been proposed to explain the association between plasma total homocysteine (tHcy) and risk of cardiovascular disease, including oxidative activity of homocysteine. OBJECTIVE: To explore the putative role of reactive oxygen species in the association between plasma tHcy and risk of cardiovascular disease in healthy individuals. DESIGN: A double-blind, placebo-controlled crossover intervention to increase folate intake through diet (increased consumption of folate-rich foods) and supplement (400 micro g folic acid) was carried out in 126 healthy men and women. Measurements were made of antioxidant activity in red blood cells and plasma, and products of oxidant damage in plasma. RESULTS: Diet and supplement-based interventions led to an increase in measures of folate status and a reduction in plasma tHcy. This was not associated with any significant change in measures of antioxidant activity (plasma and red blood cell glutathione peroxidase activity and red blood cell superoxide dismutase activity) or oxidant damage (plasma malondialdehyde), although an improvement in plasma total antioxidant capacity just failed to reach significance. CONCLUSIONS: In healthy individuals lowering plasma tHcy does not have any functional implications regarding oxidative damage.
Asunto(s)
Antioxidantes/metabolismo , Enfermedades Cardiovasculares/sangre , Ácido Fólico/administración & dosificación , Homocisteína/sangre , Adulto , Anciano , Enfermedades Cardiovasculares/epidemiología , Enfermedades Cardiovasculares/metabolismo , Estudios Cruzados , Suplementos Dietéticos , Método Doble Ciego , Femenino , Ácido Fólico/sangre , Ácido Fólico/metabolismo , Glutatión Peroxidasa/metabolismo , Homocisteína/metabolismo , Humanos , Masculino , Malondialdehído/metabolismo , Persona de Mediana Edad , Estado Nutricional , Oxidación-Reducción , Especies Reactivas de Oxígeno , Factores de Riesgo , Método Simple Ciego , Superóxido Dismutasa/metabolismoRESUMEN
OBJECTIVES: We sought to study the effect of low-dose folic acid supplementation or optimization of dietary folate intake on plasma homocysteine and endothelial function in healthy adults. BACKGROUND: Elevated homocysteine is associated with cardiovascular disease, but it is not known whether this relationship is causal. Individuals homozygous (TT) for the C677T mutation in the methylenetetrahydrofolate reductase (MTHFR) gene ( approximately 12% of the population) have increased homocysteine levels, particularly in association with suboptimal folate intake. METHODS: Healthy subjects (n = 126; 42 of each MTHFR genotype) were included in this cross-over study of three interventions of four months each: 1) placebo plus natural diet; 2) daily 400-microg folic acid supplement plus natural diet; and 3) increased dietary folate intake to 400 microg/day. RESULTS: At baseline, homocysteine was inversely related to plasma folate and was higher in TT homozygotes. For the whole group, plasma folate increased by 46% after dietary folate and by 79% after supplementation, with reductions of homocysteine of 14% and 16%, respectively. Within the genotype, TT homozygotes exhibited the most marked changes in these variables. Brachial artery endothelial function, as determined by a change in end-diastolic diameter in response to increased flow, was not changed by increased folate intake (98 +/- 73 microm at baseline, 110 +/- 69 microm after a high-folate diet, 114 +/- 59 microm after supplementation and 118 +/- 68 microm after placebo). Plasma von Willebrand factor antigen was unaltered. CONCLUSIONS: Optimization of dietary folate or low-dose folic acid supplementation reduces plasma homocysteine but does not enhance endothelial function, irrespective of the MTHFR (C667T) genotype.
Asunto(s)
Endotelio Vascular/efectos de los fármacos , Ácido Fólico/administración & dosificación , Genotipo , Homocisteína/sangre , Oxidorreductasas actuantes sobre Donantes de Grupo CH-NH/genética , Adolescente , Adulto , Anciano , Relación Dosis-Respuesta a Droga , Método Doble Ciego , Femenino , Ácido Fólico/sangre , Homocigoto , Humanos , Masculino , Metilenotetrahidrofolato Reductasa (NADPH2) , Persona de Mediana Edad , Necesidades Nutricionales , Valores de Referencia , Resistencia Vascular/genética , Resistencia Vascular/fisiologíaRESUMEN
Homocysteine is a risk factor for coronary artery disease (CAD). Folic acid lowers homocysteine and may improve endothelial function in CAD, although the mechanism is unclear. We investigated the effect of folic acid on endothelial function, homocysteine, and oxidative stress in patients with CAD. We also examined the acute effect of 5-methyltetrahydrofolate (5-MTHF), the principal circulating folate, on endothelial function in vivo and on intracellular superoxide in cultured endothelial cells. A randomized crossover study of folic acid (5 mg daily) for 6 weeks was undertaken in 52 patients with CAD. Ten further patients were given intra-arterial 5-MTHF. Endothelial function was assessed by flow-mediated dilatation (FMD). Folic acid increased plasma folate (P<0.001), lowered homocysteine by 19% (P<0.001), and improved FMD (P<0.001). FMD improvement did not correlate with homocysteine reduction. Malondialdehyde and total plasma antioxidant capacity, markers of oxidative stress, were unchanged. 5-MTHF acutely improved FMD (P<0.001) without altering homocysteine (P=0.47). In vitro, 5-MTHF abolished homocysteine-induced intracellular superoxide increase (P<0.001); this effect was also observed with folic acid and tetrahydrobiopterin. Our data support the beneficial effect of folic acid on endothelial function in CAD but suggest that the mechanism is independent of homocysteine. Reduction of intracellular endothelial superoxide may have contributed to the effect.
Asunto(s)
Biopterinas/análogos & derivados , Enfermedad Coronaria/tratamiento farmacológico , Endotelio Vascular/metabolismo , Endotelio Vascular/fisiopatología , Ácido Fólico/farmacología , Superóxidos/metabolismo , Animales , Biopterinas/farmacología , Células Cultivadas , Enfermedad Coronaria/metabolismo , Enfermedad Coronaria/fisiopatología , Estudios Cruzados , Citoplasma/metabolismo , Suplementos Dietéticos , Dilatación Patológica/tratamiento farmacológico , Dilatación Patológica/metabolismo , Dilatación Patológica/fisiopatología , Método Doble Ciego , Femenino , Ácido Fólico/sangre , Ácido Fólico/uso terapéutico , Hemodinámica/efectos de los fármacos , Homocisteína/sangre , Humanos , Inyecciones Intraarteriales , Masculino , Persona de Mediana Edad , Estrés Oxidativo , Tetrahidrofolatos/administración & dosificación , Tetrahidrofolatos/farmacología , Tetrahidrofolatos/uso terapéuticoRESUMEN
We describe the improvements created by successful implementation of a laboratory information system for a multi-institutional integrated delivery system, including an analysis of the financial results. Conditions at the outset of the project, methods of management and project design, selected aspects of services redesign and consolidation, integration of services among the sites and their effects on laboratory staff and productivity are illustrated. A method for and example of measuring the financial outcomes in the sense of quantifiable improvements in operating expenses and new revenue for a whole health system clinical laboratory computer system are discussed. In this health system, the measurable financial improvements facilitated by an information system were the ability to control operating expenses and to grow the hospital laboratory network through the development of an outreach program. With organizational commitment to process innovation and improvement, using team processes and customer-driven decision-making criteria, the financial performance of our consolidated laboratory network was enhanced substantially. A fully implemented laboratory information system is considered the major enabler of positive change when combined with a genuine commitment from all levels of staff and leadership. Over time, this system's financial return is several times that of the information system investment.
Asunto(s)
Sistemas de Información en Laboratorio Clínico/economía , Redes Comunitarias , Prestación Integrada de Atención de Salud , Análisis Costo-Beneficio , HumanosAsunto(s)
Infecciones por HTLV-I/epidemiología , Virus Linfotrópico T Tipo 1 Humano/aislamiento & purificación , Momias/virología , Pueblo Asiatico , Análisis por Conglomerados , Infecciones por HTLV-I/transmisión , Historia Antigua , Virus Linfotrópico T Tipo 1 Humano/genética , Humanos , Indígenas Sudamericanos , Japón/epidemiología , América Latina/epidemiología , Prevalencia , Provirus/genética , Provirus/aislamiento & purificaciónRESUMEN
OBJECTIVE: This work was undertaken to determine whether dietary supplementation with marine omega-3 fatty acids improve systemic large artery endothelial function in subjects with hypercholesterolemia. BACKGROUND: Marine omega-3 fatty acids improve vascular function, but the underlying mechanism(s) are unclear. We studied the effects of marine omega-3 fatty acids on large artery endothelial function in subjects with hypercholesterolemia. METHODS: Hypercholesterolemic subjects with no other known cause for endothelial dysfunction were recruited to a prospective, placebo-controlled, randomized, double-blind, parallel-group study. Treatment with omega-3 fatty acids at a dose of 4 g/day (n = 15/group) was compared with placebo, at the beginning (day 0) and end (day 120) of a four-month treatment period. Endothelial function was assessed pre- and posttreatment by noninvasive ultrasonic vessel wall tracking of brachial artery flow-mediated dilation (FMD). RESULTS: Treatment with marine omega-3 fatty acids resulted in a significant improvement in FMD (0.05 +/- 0.12 to 0.12 +/- 0.07 mm, p < 0.05) and a significant reduction in triglycerides (2.07 +/- 1.13 to 1.73 +/- 0.95 mmol/liter, p < 0.05), whereas treatment with placebo resulted in no change in FMD (0.03 +/- 0.10 to 0.04 +/- 0.10 mm) or triglycerides (2.29 +/- 2.09 to 2.05 +/- 1.36 mmol/liter) (both p < 0.05 treated compared with control). Responses to sublingual glyceryl trinitrate were unchanged. CONCLUSIONS: Marine omega-3 fatty acids improve large artery endothelium-dependent dilation in subjects with hypercholesterolemia without affecting endothelium-independent dilation.
Asunto(s)
Arteria Braquial/fisiopatología , Endotelio Vascular/fisiopatología , Ácidos Grasos Omega-3/uso terapéutico , Aceites de Pescado/uso terapéutico , Hipercolesterolemia/dietoterapia , Arteriosclerosis/prevención & control , Velocidad del Flujo Sanguíneo/efectos de los fármacos , Arteria Braquial/diagnóstico por imagen , Colesterol/sangre , Método Doble Ciego , Endotelio Vascular/diagnóstico por imagen , Femenino , Humanos , Hipercolesterolemia/diagnóstico por imagen , Hipercolesterolemia/fisiopatología , Masculino , Persona de Mediana Edad , Estudios Prospectivos , Resultado del Tratamiento , Triglicéridos/sangre , Ultrasonografía Doppler en Color , Vasodilatación/efectos de los fármacosRESUMEN
BACKGROUND: Elevated plasma homocysteine (Hcy) is a risk factor for vascular disease. A postulated mechanism is vascular endothelial damage by homocysteine. Hcy levels are inversely related to blood concentrations of folate and can be lowered by folate supplements. The effect of oral folic acid on endothelial function was investigated in healthy adults with mild hyperhomocysteinaemia. PATIENTS AND METHODS: Eighteen healthy subjects (Hcy > 13 micromol L-1 at entry), from a screening population of 890 volunteers, were entered into a randomised double-blind placebo-controlled crossover study of oral folic acid (5 mg daily for six weeks) with a six week interval between treatments. Flow-mediated (endothelium-dependent) and (endothelial-independent) glyceryl trinitrate (GTN)-mediated brachial artery dilatation were measured by high resolution wall tracking. RESULTS: Folate supplementation enhanced endothelium-dependent responses (+0.08 +/- 0.05 vs. +0.04 +/- 0.04 mm, P = 0.015) but endothelium-independent responses (GTN) were unchanged. Folate reduced Hcy (8.7 +/- 2.5 vs. 12.1 +/- 3.6 micromol L-1). CONCLUSION: High dose folic acid supplementation enhances endothelium-dependent vascular function and lowers plasma Hcy. This provides preliminary evidence that folate may have beneficial cardiovascular effects in adults with mild hyperhomocysteinaemia.
Asunto(s)
Endotelio Vascular/efectos de los fármacos , Endotelio Vascular/fisiología , Ácido Fólico/administración & dosificación , Homocisteína/sangre , Administración Oral , Adulto , Velocidad del Flujo Sanguíneo/efectos de los fármacos , Arteria Braquial/efectos de los fármacos , Arteria Braquial/fisiología , Estudios Cruzados , Método Doble Ciego , Humanos , Factores de Riesgo , Enfermedades Vasculares/etiología , Enfermedades Vasculares/prevención & control , Vasodilatación/efectos de los fármacosRESUMEN
The effects of two widely abused drugs, ethanol and cocaine, were examined alone and in combination on intracranial reward processes. In agreement with previous research, higher doses of both cocaine and ethanol alone produced facilitation of behavior maintained by brain stimulation reward. Low intraperitoneal doses of ethanol and cocaine, which alone did not affect performance, were found to reduce stimulation reward threshold and modestly increase response rate. The enhancement of brain stimulation reward by the combination of ethanol and cocaine suggests that both drugs may produce their rewarding effects through common neuronal substrates and that they may potentiate the abuse of each other.
Asunto(s)
Cocaína/metabolismo , Cocaína/farmacología , Sinergismo Farmacológico , Etanol/metabolismo , Etanol/farmacología , Hipotálamo/efectos de los fármacos , Animales , Conducta Animal/efectos de los fármacos , Relación Dosis-Respuesta a Droga , Estimulación Eléctrica , Electrodos Implantados , Masculino , Ratas , Esquema de RefuerzoRESUMEN
Jersey heifers were assigned alternately to three groups: 1) negative control (n = 41), 2) intramammary infusion of 200 mg of sodium cloxacillin (n = 38) at 7 d before expected parturition, and 3) intramammary infusion of 200 mg of cephapirin sodium (n = 36) at 7 d before expected parturition. The percentage of mammary glands infected prior to treatment was 62.2, 50.0, and 70.1 for groups 1, 2, and 3, respectively. The percentage of mammary glands infected during early lactation was 44.5, 8.6, and 2.1 for groups 1, 2, and 3, respectively. Most infections (87.1%) were due to Staphylococcus species other than Staphylococcus aureus. Thirty-six of 460 quarters were infected with major pathogens before treatment, 3 of 22 persisted following antibiotic treatment, and 9 of 14 persisted in the control group. Infusion of sodium cloxacillin resulted in antibiotic residues in 17.4% of samples obtained .5 d postpartum. All samples were negative at 3 and 10 d postpartum. Infusion of cephapirin sodium resulted in antibiotic residues in 84.7, 28.2, and 0% of samples obtained at .5, 3, and 10 d, respectively. Prepartum antibiotic therapy was effective in eliminating many IMI, especially those caused by coagulase-negative staphylococci, but there is the potential for antibiotic residues in milk.
Asunto(s)
Cefapirina/uso terapéutico , Cloxacilina/uso terapéutico , Trastornos de la Lactancia/veterinaria , Mastitis Bovina/prevención & control , Infecciones Estafilocócicas/veterinaria , Animales , Bovinos , Cefapirina/farmacocinética , Cloxacilina/farmacocinética , Calostro/metabolismo , Residuos de Medicamentos/farmacocinética , Femenino , Trastornos de la Lactancia/prevención & control , Leche/metabolismo , Embarazo , Complicaciones Infecciosas del Embarazo/tratamiento farmacológico , Complicaciones Infecciosas del Embarazo/veterinaria , Infecciones Estafilocócicas/prevención & controlRESUMEN
We have used a placebo controlled trial to investigate the effect of long-term administration of nifedipine in the prevention of symptomatic episodes of oesophageal spasm. Diary card scoring was used to assess symptoms in 8 patients with oesophageal spasm who were each given nifedipine and placebo for at least 6 weeks. No significant differences in symptoms between the nifedipine and placebo treatment periods were seen.
Asunto(s)
Enfermedades del Esófago/prevención & control , Nifedipino/uso terapéutico , Adulto , Método Doble Ciego , Evaluación de Medicamentos , Femenino , Humanos , Masculino , Persona de Mediana Edad , Espasmo/prevención & controlRESUMEN
The case histories are presented of three separate incidents of poisoning by ingestion of Hemlock Water Dropwort tubers (Oenanthe crocata). Two of these cases involved a fatality. An analytical profile is provided for oenanthotoxin, the major toxic principal of the tubers. Chromatographic, spectroscopic and mass spectral data for related compounds are also given.
Asunto(s)
Alcoholes Grasos/análisis , Intoxicación por Plantas/metabolismo , Adulto , Alquinos , Cromatografía Líquida de Alta Presión , Cromatografía en Capa Delgada , Enediinos , Femenino , Humanos , Masculino , Espectrometría de Masas , Extractos Vegetales/análisis , Espectrofotometría UltravioletaAsunto(s)
Diencéfalo/metabolismo , Dependencia de Morfina , Norepinefrina/metabolismo , Animales , Diencéfalo/efectos de los fármacos , Relación Dosis-Respuesta a Droga , Conducta de Ingestión de Líquido , Tolerancia a Medicamentos , Femenino , Humanos , Hidroxidopaminas/farmacología , Hipotálamo/análisis , Hipotálamo/efectos de los fármacos , Morfina/farmacología , Dependencia de Morfina/metabolismo , Naloxona/farmacología , Norepinefrina/análisis , Ratas , Síndrome de Abstinencia a Sustancias/tratamiento farmacológico , Tálamo/análisis , Tálamo/efectos de los fármacosRESUMEN
Fifty-three patients with megaloblastic anaemia treated with cyanocobalamin and folic acid have been studied. Repeat marrow examination was found to be of value in assessing response to treatment. The early improvement in marrow morphology in patients with pernicious anaemia was greater with 1000 mug than with 5 mug doses of cyanocobalamin. The effect of folate deficiency in delaying marrow response to cyanocobalamin in patients with pernicious anaemia is described and combined cyanocobalamin and folic acid treatment was found to be more effective than either alone. The response to large doses of cyanocobalamin in folate deficient patients was unrelated to the initial serum vitamin B12 level.
Asunto(s)
Anemia Macrocítica/tratamiento farmacológico , Anemia Megaloblástica/tratamiento farmacológico , Eritroblastos/patología , Eritrocitos/patología , Vitamina B 12/uso terapéutico , Adulto , Anciano , Anemia Megaloblástica/sangre , Examen de la Médula Ósea , Ensayos Clínicos como Asunto , Femenino , Ácido Fólico/sangre , Ácido Fólico/uso terapéutico , Deficiencia de Ácido Fólico/tratamiento farmacológico , Humanos , Hierro/sangre , Masculino , Persona de Mediana Edad , Factores de Tiempo , Vitamina B 12/sangreRESUMEN
The time of day is a decisive determinant of the effects of l-norepinephrine on feeding behavior. During the dark, direct application of l-norepinephrine to the hypothalamus of rats suppressed feeding behavior. During the light, treatment with the same dose of l-norepinephrine facilitated feeding behavior. Thus, l-norepinephrine has dual and opposite effects on feeding behavior. A hypothalamic substrate that fluctuates in a circadian rhythm could account for both actions of l-norepinephrine.